Katia Scotlandi

59PUBLICATIONS
350CO-AUTHORS
Molecular targetsGenome structure and regulationGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Aug 13, 2026
Targeting IGF2BP3 in Cancer: From Molecular Structure and Biology to Early Drug Discovery.

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Mar 27, 2026
Lamin A/C as a Molecular Link Between Nuclear Organization, Chromatin Dynamics, and Tumor Progression.

Cecilia Foglini, Katia Scotlandi, Michela Pasello

|Jan 10, 2026
Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center Experience.

Alessandro Parra, Emanuela Palmerini, Maria Antonella Laginestra

|Sep 05, 2025
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Filemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez

|Aug 21, 2025
Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition.

Femke C A S Ringnalda, Gijs J F van Son, Laurens H G Verweij

Pageof 10

Frequent Collaborators

9 joint publications

Caterina Mancarella

9 joint publications

Maria Cristina Manara

8 joint publications

Pier-Luigi Lollini

7 joint publications

Toni Ibrahim